John Spoors

Head of Commercial Medicines Policy Analysis • NHS England

John works in the Medicines Analysis Team (MAT) at NHS England and supports a number of commercial policy areas including horizon scanning, Advanced Therapy Medicinal Products (ATMPs) and managed access. John and his team work closely with commercial colleagues, the DHSC and NICE to ensure activity is based on a robust and analytical policy platform. John has degrees in politics, economics and natural sciences from the University of Manchester and Open University respectively. He has an MSc in Public Health from the London School of Hygiene and Tropical Medicine, and is currently undertaking a part-time PhD there,  looking at patient preferences in relation to ATMPs. Prior to joining NHS England in 2018, John directed and delivered global pricing and market access projects in a wide range of therapy areas across the drug development cycle

Also speaking

Takis Athanasopoulos

Director, Head of Patient Operations, Product Development & Supply Cell & Gene Therapy • GSK

Hemant Dhamne

Head of Process Development – Gene Therapy Vector Facility • King’s College London

Alan Griffith

Vice President of Research • PureSpring Therapeutics

Event Info


Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.

2022 Post-Event Report

Download the post-event report for Advanced Therapies Europe 2022.